PRNP and prion disease: In the case of prion diseases, PrP mutations including Y145X, Q160X, Y163X and Y226X [13-16] have been associated with development of CAA with perivascular PrPres amyloid, and all these mutations give rise to truncated PrP molecules which also lack the glycophosphatidylinositol (GPI) anchor.